• WuXi NextCODE Chosen To Support Singapore Precision Medicine Pilot

    Bio-IT World | The National Heart Centre of Singapore (NHCS) has chosen WuXi NextCODE to support its 18-month proof-of-concept precision medicine project, focusing on cardiovascular disease.

    Jan 4, 2017

  • Edico Genome’s Deal with Dell EMC Fits Partnership Strategy

    Xconomy | San Diego's Edico Genome is now in its fourth year as a startup, and well into the hard slog of striking partnership deals, generating revenue, and building a business.

    Jan 4, 2017

  • AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How

    Forbes | Dave Smoley has led a remarkable transformation of the information technology function at AstraZeneca during his nearly four years as CIO. He has codified the methods used to double IT's value at half the cost in ways that others can follow, as well.

    Jan 3, 2017

  • Gene Therapy To Prevent Inherited Diseases May Cause Other Ills

    NPR.org | In 2016, scientists combined the genes of three people in an effort to make a baby free of an inherited disease. But the process doesn't wipe out all faulty mitochondria, and could pose new risks.

    Jan 3, 2017

  • University of California Sues For Genia Technology Rights

    Bio-IT World Brief | Yesterday the Regents of the University of California filed a patent suit against Roger Chen and Genia Technologies in California Northern District Court.

    Dec 30, 2016

  • Building For The Future Aurora Supercomputer At Argonne

    insideHPC | Argonne National Laboratory is working on its next generation computing system: Aurora.

    Dec 29, 2016

  • How Blockchain Can Create the World’s Biggest Supercomputer

    TechCrunch | As our desktop computers, laptops, mobile devices, etc. stand idly by for a huge portion of the day, the need for computing resources is growing at a fast pace.

    Dec 28, 2016

  • Five Big Idea Biotech Trends to Watch in 2017

    Forbes | There's something especially fun about talking with scientific entrepreneurs who raised their first big wad of investment cash. They're latching onto some kernel of insight from a discovery. Here were a few trends I observed from covering startups which raised issues that will remain relevant in the year ahead.

    Dec 28, 2016

  • Local Stem Cell Biotech Mesoblast Wins Key US Investor Backing

    WA Today | The embattled stem cell biotech has seen a major US drug company becoming a cornerstone investor and taking an option over two of its main products.

    Dec 23, 2016

  • Genohub Adds Storage, Project Management Guarantees to Sequencing Marketplace

    Bio-IT World | Three years after its launch, Genohub is refining its mission, focusing on process and user experience more than just transactions. 

    Dec 21, 2016

  • Editas Medicine, Mass Innovation Labs, Sinequa, And More: News From December 2016

    Bio-IT World News Brief | News, products, and partnerships from around the bio-IT community including news from Editas Medicine, Mass Innovation Labs, Sinequa, and more.

    Dec 19, 2016

  • Scientists Say the Clock of Aging May Be Reversible

    The New York Times | The technique, discovered by a team at the Salk Institute and tested in mice, cannot be applied directly to people, but it points toward better understanding of human aging.

    Dec 19, 2016

  • Modernas Mysterious Medicines

    Forbes | Backed by world-class science, a stealthy biotech has raised $1.9 billion by promising to change medicine forever. A new lawsuit opens a rare window into its secrets.

    Dec 15, 2016

  • Google’s Long Strange Life Span Trip

    MIT Technology Review | Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google's anti-aging spinout Calico is rich enough to find out.

    Dec 15, 2016

  • Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease

    Xconomy | Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. New biotech Goldfinch Bio wants to turn genetic research into new therapies.

    Dec 14, 2016

  • New Funds for ONT, Self-Sequencing Challenge from Clive Brown

    Bio-IT World Oxford Nanopore Technologies yesterday announced $126 million in new funding through a private placement of ordinary shares. The investment round was led by new investor GT Healthcare, a pan-Asian fund with special reach in China, and existing investor Woodford Investment Management on behalf of its clients. Clive Brown, Oxford Nanopore's CTO, also released the "Cliveome" yesterday, his own self-sequenced genome.

    Dec 13, 2016

  • Complexities Of Consent

    Clinical Informatics News | As genomics continues to grow and evolve, the need to find a balance between scientific progress and patient protection is as great as ever.

    Dec 13, 2016

  • CRISPR Tech Heralds Hype, Hope, and Hurdles for Gene-Based Therapeutics

    Bio-IT World | The age of CRISPR has heralded in new lines of business based on cutting-edge, gene-editing technologies. Here are a few of the highlights of CRISPR's impact on the industry.

    Dec 12, 2016

  • First US Exascale Supercomputer Now On Track for 2021

    Top500 | The US Department of Energy's Exascale Computing Project (ECP) has changed its timeline for getting the first post-petascale system into the field. The new goal is to get an initial exascale system deployed sometime in 2021, with acceptance nine months after that. That shrinks the schedule significantly and puts the country back on a more competitive trajectory with regard to China and Japan.

    Dec 12, 2016

  • DNAnexus Reanalyzes Cancer Genome Atlas Data

    Bio-IT World Brief | DNAnexus announced today that it has performed uniform reanalysis and mutation calling on the world’s largest pan-cancer dataset, encompassing 10,487 patients across 33 cancer types from The Cancer Genome Atlas (TCGA). The mutation data has undergone additional quality control and filtering and is available as an open access dataset for download at the NCI Genomic Data Commons and on Synapse. The pipelines used are also fully available to researchers who wish to reproduce this TCGA mutation discovery via DNAnexus or a GitHub repository.

    Dec 9, 2016